Suppr超能文献

家族史与汉族人群导管原位癌和三阴性乳腺癌风险的病例对照研究。

Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study.

机构信息

Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.

出版信息

World J Surg Oncol. 2013 Oct 1;11:248. doi: 10.1186/1477-7819-11-248.

Abstract

BACKGROUND

The association between family history and risk of triple negative breast cancer and ductal carcinoma in situ (DCIS) has not been well investigated, especially in Asian populations. We investigated the association between family history and risk of DCIS or triple negative breast cancer in a Han Chinese population.

METHODS

A case-control study, comprising 926 breast cancer patients and 1,187 benign breast disease controls, was conducted in our hospital. Multivariate logistic regression was used to assess the relationships between family history and risk of DCIS or triple negative breast cancer.

RESULTS

Subjects with a family history of breast cancer had higher breast cancer risk than those without a family history (odds ratio (OR) = 2.11, 95% confidence interval (CI) = 1.26 to 3.52). Family history was not significantly associated with an increased risk of DCIS (OR = 1.27, 95% CI = 0.36 to 4.46), while family history was significantly associated with an increased risk of invasive breast cancer (OR = 2.22, 95% CI = 1.32 to 3.75), irrespective of triple negative breast cancer (OR = 3.35, 95% CI = 1.43 to 7.88) or non-triple negative breast cancer (OR = 2.14, 95% CI = 1.21 to 3.80).

CONCLUSION

Our results indicate that having a family history of breast cancer is associated with an increased risk of triple negative breast cancer with a magnitude of association similar to that for non-triple negative breast cancer. Furthermore, family history is not significantly associated with an increased risk of DCIS. Future cohort studies with larger sample sizes are still needed to explore these relationships.

摘要

背景

家族史与三阴性乳腺癌和导管原位癌(DCIS)风险之间的关联尚未得到很好的研究,尤其是在亚洲人群中。我们调查了家族史与汉族人群 DCIS 或三阴性乳腺癌风险之间的关系。

方法

在我院进行了一项病例对照研究,共纳入 926 例乳腺癌患者和 1187 例良性乳腺疾病对照。采用多变量 logistic 回归评估家族史与 DCIS 或三阴性乳腺癌风险之间的关系。

结果

有乳腺癌家族史的受试者患乳腺癌的风险高于无家族史者(比值比(OR)=2.11,95%置信区间(CI)=1.26 至 3.52)。家族史与 DCIS 风险增加无关(OR=1.27,95%CI=0.36 至 4.46),而家族史与浸润性乳腺癌风险增加显著相关(OR=2.22,95%CI=1.32 至 3.75),无论是否为三阴性乳腺癌(OR=3.35,95%CI=1.43 至 7.88)或非三阴性乳腺癌(OR=2.14,95%CI=1.21 至 3.80)。

结论

我们的研究结果表明,有乳腺癌家族史与三阴性乳腺癌风险增加相关,其关联程度与非三阴性乳腺癌相似。此外,家族史与 DCIS 风险增加无关。仍需要更大样本量的队列研究来进一步探讨这些关系。

相似文献

3
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
Breast Cancer Res. 2021 Oct 30;23(1):101. doi: 10.1186/s13058-021-01479-8.
4
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2222-31. doi: 10.1158/1055-9965.EPI-11-0569. Epub 2011 Jul 27.
7
Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
Cancer Control. 2017 Jan;24(1):102-110. doi: 10.1177/107327481702400117.
8
Genomic landscape of ductal carcinoma in situ and association with progression.
Breast Cancer Res Treat. 2019 Nov;178(2):307-316. doi: 10.1007/s10549-019-05401-x. Epub 2019 Aug 17.
9
Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
Cancer Rep (Hoboken). 2020 Jun;3(3):e1248. doi: 10.1002/cnr2.1248. Epub 2020 May 28.

引用本文的文献

1
Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer.
Breast Cancer Res Treat. 2021 Sep;189(2):483-495. doi: 10.1007/s10549-021-06294-5. Epub 2021 Jun 29.
2
SNHG1 Long Noncoding RNA is Potentially Up-Regulated in Colorectal Adenocarcinoma.
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):897-901. doi: 10.31557/APJCP.2020.21.4.897.
3
A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors.
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):867-880. doi: 10.31557/APJCP.2020.21.4.867.
4
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.
PLoS One. 2017 Oct 6;12(10):e0184181. doi: 10.1371/journal.pone.0184181. eCollection 2017.
5
Family history in breast cancer in São Luís, Maranhão, Brazil.
BMC Res Notes. 2016 Mar 10;9:155. doi: 10.1186/s13104-015-1471-7.
6
Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women.
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):366-73. doi: 10.1158/1055-9965.EPI-15-1068. Epub 2015 Dec 31.

本文引用的文献

1
The prevalence and correlates of breast cancer among women in Eastern China.
PLoS One. 2012;7(6):e37784. doi: 10.1371/journal.pone.0037784. Epub 2012 Jun 18.
3
The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.
Br J Cancer. 2012 May 8;106(10):1611-7. doi: 10.1038/bjc.2012.151. Epub 2012 Apr 19.
4
Family history and breast cancer hormone receptor status in a Spanish cohort.
PLoS One. 2012;7(1):e29459. doi: 10.1371/journal.pone.0029459. Epub 2012 Jan 6.
5
The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.
PLoS One. 2011;6(5):e20297. doi: 10.1371/journal.pone.0020297. Epub 2011 May 31.
6
The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis.
J Cancer Res Clin Oncol. 2011 Jul;137(7):1053-60. doi: 10.1007/s00432-011-0979-z. Epub 2011 Apr 17.
7
Clinical assessment of breast cancer risk based on family history.
J Natl Compr Canc Netw. 2010 Oct;8(10):1148-55. doi: 10.6004/jnccn.2010.0084.
8
Ductal carcinoma in situ: risk factors and impact of screening.
J Natl Cancer Inst Monogr. 2010;2010(41):113-6. doi: 10.1093/jncimonographs/lgq024.
9
Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.
Breast Cancer Res Treat. 2011 Apr;126(3):671-8. doi: 10.1007/s10549-010-1148-9. Epub 2010 Sep 3.
10
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients.
Breast Cancer Res Treat. 2009 May;115(2):325-33. doi: 10.1007/s10549-008-0096-0. Epub 2008 Jun 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验